近岸蛋白 funding history / development milestones

IPO上市,

2022.09.29,上交所

Note: collected from public online reports, for reference only.

People who follow 近岸蛋白 also follow

近岸蛋白 Competitors (Similar Companies)

分子生物学试剂 基因工程 酵母 生物试剂
“To develop high-quality biologics that are accessible and affordable f”
生命科学 生物信息 生物制药 干细胞
“Specializing in R&D, production, and sales of high-precision, high-per”
“Brand of protein reagents for target drug development”
“Providing solutions for personalized treatment and health management”
“Dedicated to the research and development of molecularly targeted drug”
“In Vitro Diagnostics Reagent Raw Materials and Solution Provider”
“Gene technology benefits humanity”
“Continuously innovating to bring patients medicines that significantly”
“Innovative chemical products and services provider in the drug researc”
“Technological innovation and commercial application of pharmaceutical ”
“A research and development institution in cell and molecular biology d”
制药/药业 抗体 蛋白质工程 生物制药
“Peptides, chemical and biological APIs and preparations”